Detalhe da pesquisa
1.
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 128(3): 519-528, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605020
2.
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 125(13): 2291-2299, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901086
3.
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
Haematologica
; 100(12): 1579-86, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430172
4.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315846
5.
Nature and importance of follicular lymphoma precursors.
Haematologica
; 99(5): 802-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24790058
6.
Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.
Haematologica
; 100(4): e155-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527563
7.
Strategies for improving outcomes with 14-day anthracycline-based regimens in patients with aggressive lymphomas.
Clin Lymphoma Myeloma
; 8 Suppl 2: S50-6, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18284716
8.
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.
Leuk Lymphoma
; 57(5): 1149-53, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26879408
9.
Large B-cell lymphomas in adolescents and young adults in comparison to adult patients: a matched-control analysis in 55 patients.
Leuk Lymphoma
; 55(8): 1849-53, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24160849
10.
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
Leuk Lymphoma
; 55(11): 2508-13, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24506467
11.
Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.
Arch Immunol Ther Exp (Warsz)
; 61(2): 165-74, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23283519
12.
Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.
Leuk Lymphoma
; 54(11): 2392-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23410100
13.
Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study.
Leuk Lymphoma
; 51(3): 399-405, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20038227
14.
Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Arch Immunol Ther Exp (Warsz)
; 58(2): 131-41, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20191326
15.
Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
J Clin Oncol
; 28(12): 2094-100, 2010 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20308668